The LIG4 Ile658Val polymorphism does not affect the risk of cervical carcinoma

Pathology Research and Practice

Volumn 206, Issue 8, 2010, Pages 556-559

  Ding, Zhiming ^a   Zhang, Jing ^a   Cheng, Qi ^b   Shen, Jiajie ^b   Hu, Yuting ^b   Chen, Huaizeng ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Zhejiang University School of Medicine   (China)

Author keywords

Cervical carcinoma; LIG4 Ile658Val; Single nucleotide polymorphism

Indexed keywords

LIGASE; LIGASE 4; UNCLASSIFIED DRUG; DNA LIGASE (ATP); POLYDEOXYRIBONUCLEOTIDE SYNTHASE;

ADULT; ARTICLE; CANCER RISK; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CARCINOMA; ASIAN CONTINENTAL ANCESTRY GROUP; CANCER STAGING; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; UTERINE CERVIX TUMOR;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; DNA LIGASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 77954311197     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2010.03.001     Document Type: Article

References (23)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55:74-108.
2. Giuliano A.R., Harris R., Sedjo R.L., Baldwin S., Roe D., Papenfuss M.R., et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J. Infect. Dis. 2002, 186:462-469.
3. Hamel N., Black M.J., Ghadirian P., Foulkes W.D. No association between P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck. Br. J. Cancer 2000, 82:757-759.
4. Ngan H.Y., Liu V.W., Liu S.S. Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53. Br. J. Cancer 1999, 80:1828-1829.
5. Giannoudis A., Graham D.A., Southern S.A., Herrington C.S. p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low- and high-grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix. Int. J. Cancer 1999, 83:66-69.
6. Minaguchi T., Kanamori Y., Matsushima M., Yoshikawa H., Taketani Y., Nakamura Y. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res. 1998, 58:4585-4586.
7. Ye F., Zhang J., Cheng Q., Shen J., Chen H. p53 Codon 72 polymorphism is associated with occurrence of cervical carcinoma in the Chinese population. Cancer Lett. 2010, 287:117-121.
8. Dokianakis D.N., Spandidos D.A. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer. Mol. Cell. Biol. Res. Commun. 2000, 3:111-114.
9. Zehbe I., Voglino G., Wilander E., Genta F., Tommasino M. Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet 1999, 354:218-219.
10. Yamashita T., Yaginuma Y., Saitoh Y., Kawai K., Kurakane T., Hayashi H., et al. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix. Carcinogenesis 1999, 20:1733-1736.
11. Zehbe I., Voglino G., Wilander E., Delius H., Marongiu A., Edler L., et al. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer Res. 2001, 61:608-611.
12. Khanna K.K., Jackson S.P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 2001, 27:247-254.
13. Taccioli G.E., Rathbun G., Oltz E., Stamato T., Jeggo P.A., Alt F.W. Impairment of V(D)J recombination in double-strand break repair mutants. Science 1993, 260:207-210.
14. Grawunder U., Zimmer D., Kulesza P., Lieber M.R. Requirement for an interaction of XRCC4 with DNA ligase IV for wild-type V(D)J recombination and DNA double-strand break repair in vivo. J. Biol. Chem. 1998, 273:24708-24714.
15. Gao Y., Ferguson D.O., Xie W., Manis J.P., Sekiguchi J., Frank K.M., et al. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 2000, 404:897-900.
16. Ferguson D.O., Sekiguchi J.M., Chang S., Frank K.M., Gao Y., DePinho R.A., et al. The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:6630-6633.
17. Sekiguchi J., Ferguson D.O., Chen H.T., Yang E.M., Earle J., Frank K., et al. Genetic interactions between ATM and the nonhomologous end-joining factors in genomic stability and development. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:3243-3248.
18. Frank K.M., Sharpless N.E., Gao Y., Sekiguchi J.M., Ferguson D.O., Zhu C., et al. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol. Cell 2000, 5:993-1002.
19. Tseng R.C., Hsieh F.J., Shih C.M., Hsu H.S., Chen C.Y., Wang Y.C. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study. Cancer 2009, 115:2939-2948.
20. Sakiyama T., Kohno T., Mimaki S., Ohta T., Yanagitani N., Sobue T., et al. Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Int. J. Cancer 2005, 114:730-737.
21. Damaraju S., Murray D., Dufour J., Carandang D., Myrehaug S., Fallone G., et al. Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin. Cancer Res. 2006, 12:2545-2554.
22. Kuschel B., Auranen A., McBride S., Novik K.L., Antoniou A., et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum. Mol. Genet. 2002, 11:1399-1407.
23. García-Closas M., Egan K.M., Newcomb P.A., Brinton L.A., Titus-Ernstoff L., Chanock S., et al. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum. Genet. 2006, 119:376-388.